BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16885348)

  • 1. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
    Strock CJ; Park JI; Nakakura EK; Bova GS; Isaacs JT; Ball DW; Nelkin BD
    Cancer Res; 2006 Aug; 66(15):7509-15. PubMed ID: 16885348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling.
    Liu JL; Gu RX; Zhou XS; Zhou FZ; Wu G
    Mol Med Rep; 2015 Sep; 12(3):3979-3985. PubMed ID: 26018459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
    Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
    Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Eggers JP; Grandgenett PM; Collisson EC; Lewallen ME; Tremayne J; Singh PK; Swanson BJ; Andersen JM; Caffrey TC; High RR; Ouellette M; Hollingsworth MA
    Clin Cancer Res; 2011 Oct; 17(19):6140-50. PubMed ID: 21825040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.
    Bosutti A; Qi J; Pennucci R; Bolton D; Matou S; Ali K; Tsai LH; Krupinski J; Petcu EB; Montaner J; Al Baradie R; Caccuri F; Caruso A; Alessandri G; Kumar S; Rodriguez C; Martinez-Gonzalez J; Slevin M
    PLoS One; 2013; 8(9):e75538. PubMed ID: 24098701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
    Demelash A; Rudrabhatla P; Pant HC; Wang X; Amin ND; McWhite CD; Naizhen X; Linnoila RI
    Mol Biol Cell; 2012 Aug; 23(15):2856-66. PubMed ID: 22696682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line.
    Kuo HS; Hsu FN; Chiang MC; You SC; Chen MC; Lo MJ; Lin H
    Chin J Physiol; 2009 Feb; 52(1):23-30. PubMed ID: 19764350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
    Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
    Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.
    Oner M; Lin E; Chen MC; Hsu FN; Shazzad Hossain Prince GM; Chiu KY; Teng CJ; Yang TY; Wang HY; Yue CH; Yu CH; Lai CH; Hsieh JT; Lin H
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.
    Liebl J; Weitensteiner SB; Vereb G; Takács L; Fürst R; Vollmar AM; Zahler S
    J Biol Chem; 2010 Nov; 285(46):35932-43. PubMed ID: 20826806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.
    Feldmann G; Mishra A; Hong SM; Bisht S; Strock CJ; Ball DW; Goggins M; Maitra A; Nelkin BD
    Cancer Res; 2010 Jun; 70(11):4460-9. PubMed ID: 20484029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
    He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
    Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of inside-out β1-integrin activation by CDCP1.
    Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
    Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p35 is required for CDK5 activation in cellular senescence.
    Mao D; Hinds PW
    J Biol Chem; 2010 May; 285(19):14671-80. PubMed ID: 20181942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
    Sharma S; Zhang T; Michowski W; Rebecca VW; Xiao M; Ferretti R; Suski JM; Bronson RT; Paulo JA; Frederick D; Fassl A; Boland GM; Geng Y; Lees JA; Medema RH; Herlyn M; Gygi SP; Sicinski P
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8001-8012. PubMed ID: 32193336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
    Ubeda M; Kemp DM; Habener JF
    Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.
    Wissing MD; Dadon T; Kim E; Piontek KB; Shim JS; Kaelber NS; Liu JO; Kachhap SK; Nelkin BD
    Oncol Rep; 2014 Jul; 32(1):419-24. PubMed ID: 24841903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
    Goodyear S; Sharma MC
    Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.